Your browser doesn't support javascript.
loading
A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA).
Pang, T; Bain, S C; Black, R Neil A; Boyle, J G; Elliott, J; Holcombe, A; Lee, K C S; Mulligan, C; Saunders, L; Yousseif, A; Baxter, M.
Afiliação
  • Pang T; Dudley Group NHS Foundation Trust, Russells Hall Hospital, Dudley.
  • Bain SC; Institute of Life Science, Swansea University Medical School, Swansea.
  • Black RNA; Department of Endocrinology and Diabetes, Altnagelvin Hospital, Derry.
  • Boyle JG; Glasgow Royal Infirmary, School of Medicine, University of Glasgow, Glasgow.
  • Elliott J; Diabetes and Endocrine Department, Sheffield Teaching Hospitals, Sheffield.
  • Holcombe A; North East Essex Diabetes Service, Suffolk GP Federation, Colchester.
  • Lee KCS; Sanofi, Guildford.
  • Mulligan C; Ulster Hospital, SE Trust, Belfast.
  • Saunders L; pH Associates, Marlow.
  • Yousseif A; Diabetes and Endocrine Department, Royal Free London NHS Foundation Trust, London, UK.
  • Baxter M; Sanofi, Guildford.
Diabet Med ; 36(1): 110-119, 2019 01.
Article em En | MEDLINE | ID: mdl-30362181

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Glicemia / Cetoacidose Diabética / Diabetes Mellitus Tipo 1 / Insulina Glargina Tipo de estudo: Evaluation_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Glicemia / Cetoacidose Diabética / Diabetes Mellitus Tipo 1 / Insulina Glargina Tipo de estudo: Evaluation_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article